Review

. 2019 Jun:166:66-81.

doi: 10.1016/j.antiviral.2019.03.009. Epub 2019 Mar 21.

GloPID-R report on Chikungunya, O'nyong-nyong and Mayaro virus, part I: Biological diagnostics

L Pezzi¹, C B Reusken², S C Weaver³, J F Drexler⁴, M Busch⁵, A D LaBeaud⁶, M S Diamond⁷, N Vasilakis⁸, M A Drebot⁹, A M Siqueira¹⁰, G S Ribeiro¹¹, A Kohl¹², M Lecuit¹³, L F P Ng¹⁴, P Gallian¹⁵, X de Lamballerie¹⁶; GloPID-R Chikungunya, O'nyong-nyong and Mayaro virus Working Group

Collaborators, Affiliations

Collaborators

GloPID-R Chikungunya, O'nyong-nyong and Mayaro virus Working Group:
S Boyer¹⁷, P Brasil¹⁰, M Diallo¹⁸, A B Failloux¹⁹, T Jaenisch²⁰, R Lourenço-de-Oliveira²¹, J Neyts²², M Rios²³, A J Rodriguez-Morales²⁴, M G Rosa-Freitas²¹, A Sall¹⁸, G Simmons²⁵, F Simon²⁶, A Vega Rua²⁷

Affiliations

¹ Unité des Virus Émergents (UVE: Aix-Marseille Univ-IRD 190-Inserm 1207-IHU Méditerranée Infection), Marseille, France; EA7310, Laboratoire de Virologie, Université de Corse-Inserm, Corte, France. Electronic address: laura.pezzi3@studio.unibo.it.
² Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands; Department Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands.
³ Institute for Human Infections and Immunity and Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, USA.
⁴ Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Virology, 10117 Berlin, Germany; German Centre for Infection Research (DZIF), Germany.
⁵ Blood Systems Research Institute, San Francisco, and Department of Laboratory Medicine, University of California, San Francisco, USA.
⁶ Department of Pediatrics, Division of Infectious Diseases, Stanford University School of Medicine, Stanford, USA.
⁷ Department of Medicine, and The Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St. Louis, USA; Department of Molecular Microbiology, and The Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St. Louis, USA; Department of Pathology and Immunology, and The Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St. Louis, USA.
⁸ Department of Pathology, Institute of Human Infection and Immunity, University of Texas Medical Branch, Galveston, USA.
⁹ Zoonotic Diseases and Special Pathogens, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada.
¹⁰ Instituto Nacional de Infectologia Evandro Chagas - Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
¹¹ Gonçalo Moniz Institute, Oswaldo Cruz Foundation, and Federal University of Bahia, Salvador, Brazil.
¹² MRC-University of Glasgow Centre for Virus Research, Glasgow, UK.
¹³ Institut Pasteur, Biology of Infection Unit, Inserm U1117, Paris Descartes University, Departement of Infectious Diseases and Tropical Medicine, Necker-Enfants Malades University Hospital, APHP, IHU Imagine, Paris, France.
¹⁴ Singapore Immunology Network, Agency for Science, Technology and Research (A*STAR), Singapore.
¹⁵ Établissement Français du Sang Alpes Méditerranée, Marseille, France.
¹⁶ Unité des Virus Émergents (UVE: Aix-Marseille Univ-IRD 190-Inserm 1207-IHU Méditerranée Infection), Marseille, France.
¹⁷ Medical Entomology Platform, Institut Pasteur du Cambodge, Phnom Penh, Cambodia.
¹⁸ Unité d'Entomologie Médicale, Institut Pasteur de Dakar, Dakar, Senegal.
¹⁹ Department of Virology, Institut Pasteur, Arboviruses and Insect Vectors Unit, Paris, France.
²⁰ Section Clinical Tropical Medicine, Department of Infectious Diseases, Heidelberg University Hospital, Heidelberg, Germany.
²¹ Instituto Oswaldo Cruz-Fiocruz, Laboratório de Mosquitos Transmissores de Hematozoários, Rio de Janeiro, Brazil.
²² KU Leuven, Department of Microbiology and Immunology, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, Leuven, Belgium.
²³ Division of Emerging and Transfusion Transmitted Diseases, Laboratory of Emerging Pathogens, Office of Blood Research and Review, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, USA.
²⁴ Public Health and Infection Research Group, Faculty of Health Sciences, Universidad Tecnologica de Pereira, Pereira, Colombia.
²⁵ Blood Systems Research Institute, San Francisco, USA, and Department of Pathology and Laboratory Medicine, University of California, San Francisco, San Francisco, USA.
²⁶ Laveran Military Teaching Hospital, Marseille, France.
²⁷ Laboratory of Vector Control Research, Environment and Health Unit, Institut Pasteur de la Guadeloupe, Guadeloupe.

PMID: 30905821
DOI: 10.1016/j.antiviral.2019.03.009

Free article

Review

GloPID-R report on Chikungunya, O'nyong-nyong and Mayaro virus, part I: Biological diagnostics

L Pezzi et al. Antiviral Res. 2019 Jun.

Free article

. 2019 Jun:166:66-81.

doi: 10.1016/j.antiviral.2019.03.009. Epub 2019 Mar 21.

Authors

Collaborators

GloPID-R Chikungunya, O'nyong-nyong and Mayaro virus Working Group:
S Boyer¹⁷, P Brasil¹⁰, M Diallo¹⁸, A B Failloux¹⁹, T Jaenisch²⁰, R Lourenço-de-Oliveira²¹, J Neyts²², M Rios²³, A J Rodriguez-Morales²⁴, M G Rosa-Freitas²¹, A Sall¹⁸, G Simmons²⁵, F Simon²⁶, A Vega Rua²⁷

Affiliations

¹ Unité des Virus Émergents (UVE: Aix-Marseille Univ-IRD 190-Inserm 1207-IHU Méditerranée Infection), Marseille, France; EA7310, Laboratoire de Virologie, Université de Corse-Inserm, Corte, France. Electronic address: laura.pezzi3@studio.unibo.it.
² Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands; Department Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands.
³ Institute for Human Infections and Immunity and Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, USA.
⁴ Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Virology, 10117 Berlin, Germany; German Centre for Infection Research (DZIF), Germany.
⁵ Blood Systems Research Institute, San Francisco, and Department of Laboratory Medicine, University of California, San Francisco, USA.
⁶ Department of Pediatrics, Division of Infectious Diseases, Stanford University School of Medicine, Stanford, USA.
⁷ Department of Medicine, and The Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St. Louis, USA; Department of Molecular Microbiology, and The Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St. Louis, USA; Department of Pathology and Immunology, and The Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St. Louis, USA.
⁸ Department of Pathology, Institute of Human Infection and Immunity, University of Texas Medical Branch, Galveston, USA.
⁹ Zoonotic Diseases and Special Pathogens, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada.
¹⁰ Instituto Nacional de Infectologia Evandro Chagas - Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
¹¹ Gonçalo Moniz Institute, Oswaldo Cruz Foundation, and Federal University of Bahia, Salvador, Brazil.
¹² MRC-University of Glasgow Centre for Virus Research, Glasgow, UK.
¹³ Institut Pasteur, Biology of Infection Unit, Inserm U1117, Paris Descartes University, Departement of Infectious Diseases and Tropical Medicine, Necker-Enfants Malades University Hospital, APHP, IHU Imagine, Paris, France.
¹⁴ Singapore Immunology Network, Agency for Science, Technology and Research (A*STAR), Singapore.
¹⁵ Établissement Français du Sang Alpes Méditerranée, Marseille, France.
¹⁶ Unité des Virus Émergents (UVE: Aix-Marseille Univ-IRD 190-Inserm 1207-IHU Méditerranée Infection), Marseille, France.
¹⁷ Medical Entomology Platform, Institut Pasteur du Cambodge, Phnom Penh, Cambodia.
¹⁸ Unité d'Entomologie Médicale, Institut Pasteur de Dakar, Dakar, Senegal.
¹⁹ Department of Virology, Institut Pasteur, Arboviruses and Insect Vectors Unit, Paris, France.
²⁰ Section Clinical Tropical Medicine, Department of Infectious Diseases, Heidelberg University Hospital, Heidelberg, Germany.
²¹ Instituto Oswaldo Cruz-Fiocruz, Laboratório de Mosquitos Transmissores de Hematozoários, Rio de Janeiro, Brazil.
²² KU Leuven, Department of Microbiology and Immunology, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, Leuven, Belgium.
²³ Division of Emerging and Transfusion Transmitted Diseases, Laboratory of Emerging Pathogens, Office of Blood Research and Review, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, USA.
²⁴ Public Health and Infection Research Group, Faculty of Health Sciences, Universidad Tecnologica de Pereira, Pereira, Colombia.
²⁵ Blood Systems Research Institute, San Francisco, USA, and Department of Pathology and Laboratory Medicine, University of California, San Francisco, San Francisco, USA.
²⁶ Laveran Military Teaching Hospital, Marseille, France.
²⁷ Laboratory of Vector Control Research, Environment and Health Unit, Institut Pasteur de la Guadeloupe, Guadeloupe.

PMID: 30905821
DOI: 10.1016/j.antiviral.2019.03.009

Abstract

The GloPID-R (Global Research Collaboration for Infectious Disease Preparedness) Chikungunya (CHIKV), O'nyong-nyong (ONNV) and Mayaro virus (MAYV) Working Group is investigating the natural history, epidemiology and medical management of infection by these viruses, to identify knowledge gaps and to propose recommendations for direct future investigations and rectification measures. Here, we present the first report dedicated to diagnostic aspects of CHIKV, ONNV and MAYV. Regarding diagnosis of the disease at the acute phase, molecular assays previously described for the three viruses require further evaluation, standardized protocols and the availability of international standards representing the genetic diversity of the viruses. Detection of specific IgM would benefit from further investigations to clarify the extent of cross-reactivity among the three viruses, the sensitivity of the assays, and the possible interfering role of cryoglobulinaemia. Implementation of reference panels and external quality assessments for both molecular and serological assays is necessary. Regarding sero-epidemiological studies, there is no reported high-throughput assay that can distinguish among these different viruses in areas of potential co-circulation. New specific tools and/or improved standardized protocols are needed to enable large-scale epidemiological studies of public health relevance to be performed. Considering the high risk of future CHIKV, MAYV and ONNV outbreaks, the Working Group recommends that a major investigation should be initiated to fill the existing diagnostic gaps.

Keywords: Alphavirus; Chikungunya virus; Diagnostics; Mayaro virus; O'nyong-nyong.

PubMed Disclaimer

Cited by

Rapid diagnostic test: a critical need for outbreak preparedness and response for high priority pathogens.
Yimer SA, Booij BB, Tobert G, Hebbeler A, Oloo P, Brangel P, L'Azou Jackson M, Jarman R, Craig D, Avumegah MS, Mandi H, Endy T, Wooden S, Clark C, Bernasconi V, Shurtleff A, Kristiansen PA. Yimer SA, et al. BMJ Glob Health. 2024 Apr 30;9(4):e014386. doi: 10.1136/bmjgh-2023-014386. BMJ Glob Health. 2024. PMID: 38688565 Free PMC article. Review.
Seroprevalence of Alphaviruses (Togaviridae) among Urban Population in Nouakchott, Mauritania, West Africa.
Abdoullah B, Durand GA, Basco LK, El Bara A, Bollahi MA, Bosio L, Geulen M, Briolant S, Boukhary AOMS. Abdoullah B, et al. Viruses. 2023 Jul 20;15(7):1588. doi: 10.3390/v15071588. Viruses. 2023. PMID: 37515274 Free PMC article.
Assessment of Post-Dengue Rheumatic Symptoms Using the WOMAC and DAS-28 Questionnaires in a Honduran Population after a Four-Month Follow-Up.
Zambrano LI, Fuentes-Barahona IC, Portillo-Pineda R, Aguilar-Ponce M, Murillo-Padilla JC, Suazo-Menocal M, Antunez-Salgado C, Medina-Bassilet E, Muñoz-Lara F, Bonilla-Aldana DK, Montenegro-Idrogo JJ, Rodríguez-Morales AJ. Zambrano LI, et al. Trop Med Infect Dis. 2022 Nov 23;7(12):394. doi: 10.3390/tropicalmed7120394. Trop Med Infect Dis. 2022. PMID: 36548649 Free PMC article.
Seroepidemiological Reconstruction of Long-term Chikungunya Virus Circulation in Burkina Faso and Gabon.
Lim JK, Ridde V, Agnandji ST, Lell B, Yaro S, Yang JS, Hoinard D, Weaver SC, Vanhomwegen J, Salje H, Yoon IK. Lim JK, et al. J Infect Dis. 2023 Jan 11;227(2):261-267. doi: 10.1093/infdis/jiac246. J Infect Dis. 2023. PMID: 35710849 Free PMC article.
Incidence of chikungunya virus infections among Kenyan children with neurological disease, 2014-2018: A cohort study.
Nyamwaya DK, Otiende M, Mwango L, Kariuki SM, Otieno B, Omuoyo DO, Githinji G, Kitsao BS, Karanja HK, Gitonga JN, de Laurent ZR, Davies A, Mwarumba S, Agoti CN, Thumbi SM, Hamaluba MM, Newton CR, Bejon P, Warimwe GM. Nyamwaya DK, et al. PLoS Med. 2022 May 12;19(5):e1003994. doi: 10.1371/journal.pmed.1003994. eCollection 2022 May. PLoS Med. 2022. PMID: 35550620 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

Grants and funding

MC_UU_12014/8/MRC_/Medical Research Council/United Kingdom

LinkOut - more resources

Full Text Sources
Medical
- Genetic Alliance
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

GloPID-R report on Chikungunya, O'nyong-nyong and Mayaro virus, part I: Biological diagnostics

Collaborators

Affiliations

GloPID-R report on Chikungunya, O'nyong-nyong and Mayaro virus, part I: Biological diagnostics

Authors

Collaborators

Affiliations

Abstract

Similar articles

Cited by

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Medical

Abstract

Similar articles

Cited by

Publication types

MeSH terms

Substances

Related information

Grants and funding

LinkOut - more resources

Full Text Sources

Medical